Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Acute Rectal Toxicity for Hypofractionated Prostate Radiotherapy - An Multi-institution Pilot Study of Reduced PTV Margin

NCT04004858 is registered in ClinicalTrials.gov with Southlake Health as lead sponsor.

NCT NCT04004858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04004858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Acute Rectal Toxicity for Hypofractionated Prostate Radiotherapy - An Multi-institution Pilot Study of Reduced PTV Margin
Lead sponsor
Southlake Health
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2019
Completion date
August 1, 2021
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer